Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Fusidic acid successfully treated a rare scalp infection with hair regrowth and no recurrence after 6 months.

Minoxidil not effective in preventing chemotherapy-induced hair loss.

A 28-day treatment successfully cured a dog's skin infection, restoring its hair and skin health.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

4-azasteroids, including finasteride, can inhibit 5α-reductase, helping treat conditions like enlarged prostate and hair loss.

SIG-1451 could be a promising new treatment for atopic dermatitis.

A new compound shows promise as a topical treatment for hair loss.

Indinavir, especially with vitamin A, may cause bone changes, but switching to nelfinavir can reduce these effects.

Oral JAK inhibitors are safe for alopecia areata, but baricitinib may cause more acne and infections.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

Finasteride can cause itching, burning, and other side effects that may not go away after treatment.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

Tirzepatide improved symptoms and hair regrowth in a man with folliculitis decalvans.

A patient with a nerve disorder died from infection complications after developing insulin resistance from a treatment.

The new cocrystal KET-PABA is a more effective and safe anti-inflammatory treatment for skin conditions in mice.

Tacrolimus is a better option than cyclosporine due to fewer side effects.

New psoriasis treatments are effective but come with side effects and risks.

Certain genetic variations can make people more likely to experience hair loss and low white blood cell count from azathioprine.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

The extract of Guazuma ulmifolia Lam. has limited antioxidant properties and cannot prevent uric acid synthesis.

Ketoconazole shampoo treats dandruff and reduces hair greasiness.

Ruxolitinib can cause a delayed skin reaction on the nose.